The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Sarcoid-like granulomatosis (endo-/extrathoracic)
Publications
A Case of Adalimumab-Induced Granulomatous Interstitial Nephritis.
Cureus 2021 Jun;13;e15986 — 2021 Jun — e15986
Pulmonary Sarcoidosis in Behçet's Disease Treated with Adalimumab.
European journal of case reports in internal medicine 2017;4;000576 — 2017 — 000576
Granulomatous interstitial nephritis secondary to adalimumab therapy.
Clinical kidney journal 2018 Apr;11;219-221 — 2018 Apr — 219-221
Adalimumab-induced pulmonary sarcoidosis not progressing upon treatment with etanercept.
Zeitschrift fur Rheumatologie 2017 May;76;372-374 — 2017 May — 372-374
Adalimumab Induced Subcutaneous Nodular Sarcoidosis; A Rare Side Effect of Tumor Necrosis Factor-? Inhibitor.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG 2014 Oct 20;31;249-51 — 2014 Oct 20 — 249-51
Hemidiaphragm paresis and granulomatous pneumonitis associated with adalimumab: a case report.
Heart & lung : the journal of critical care 2014 Jan-Feb;43;84-6 — 2014 Jan-Feb — 84-6
Sarcoid-like granulomatosis in patients treated with anti-TNF? factors. A case report and review of the literature.
Clinical rheumatology 2011 Apr;30;581-3 — 2011 Apr — 581-3